fda.gov vs nejm.org
Market traction comparison · Updated Jul 2026
| fda.gov | nejm.org | Leads | |
|---|---|---|---|
| Monthly Visits | 8.5M | 4.0M | fda.gov |
| Bounce Rate | 59.1% | 41.0% | nejm.org |
| SEO & Keywords | 30 | 30 | Tie |
| Domain Age | 26y 1m | 31y 11m | nejm.org |
nejm.org leads in 2 of 4 dimensions, while fda.gov leads in 1.
Growth Momentum
| fda.gov | nejm.org | Leads | |
|---|---|---|---|
| Monthly Visits | 8.5M | 4.0M | fda.gov |
| MoM Change | +25% | -1% | fda.gov |
| Avg. Session | 2m15s | 2m27s | nejm.org |
| Pages / Visit | 2.5 | 3.3 | nejm.org |
Growth Momentum · Insight
nejm.org is losing traffic (-1%) despite 4.0M monthly visits. fda.gov's +25% growth puts it on a trajectory to overtake.
Acquisition Strategy
| fda.gov | nejm.org | Leads | |
|---|---|---|---|
| Primary Channel | Search 52% | Direct 40% | |
| Bounce Rate | 59.1% | 41.0% | nejm.org |
| SEO & Keywords | 30 | 30 | — |
Keyword Overlap Rate: 13%
| Keyword | Volume | fda.gov | nejm.org |
|---|---|---|---|
| medical ai | 12.4K | #6 | #8 |
Acquisition Strategy · Insight
fda.gov acquires users primarily through Search (52%), while nejm.org relies on Direct (40%). This reflects fundamentally different go-to-market strategies — nejm.org's higher direct traffic suggests stronger brand recognition or product-led growth, while fda.gov's search reliance means growth is more scalable but more vulnerable to algorithm changes.
Business Maturity
| fda.gov | nejm.org | Leads | |
|---|---|---|---|
| Domain Age | 26y 1m | 31y 11m | nejm.org |
| Registered | Jul 2000 | Oct 1994 | |
| Expires | Aug 2026 | Oct 2026 |
Business Maturity · Insight
nejm.org has been in the market for over a decade, indicating established presence.
Market Position
| fda.gov | nejm.org | Leads | |
|---|---|---|---|
| Global Rank | #7.9K | #14.5K | fda.gov |
| Category Rank | #4 | #145 | fda.gov |
fda.gov only
nejm.org only
Market Position · Insight
Each has untapped markets the other serves: fda.gov could expand into Canada, Australia, United Kingdom, while nejm.org could target India, China, South Korea.
Key Takeaways
- •nejm.org is losing traffic (-1%) despite 4.0M monthly visits. fda.gov's +25% growth puts it on a trajectory to overtake.
- •fda.gov acquires users primarily through Search (52%), while nejm.org relies on Direct (40%). This reflects fundamentally different go-to-market strategies — nejm.org's higher direct traffic suggests stronger brand recognition or product-led growth, while fda.gov's search reliance means growth is more scalable but more vulnerable to algorithm changes.
- •fda.gov receives 2.1x more monthly traffic than nejm.org (8.5M vs 4.0M).
- •fda.gov is growing (+25%) while nejm.org is declining (-1%).
- •nejm.org has a 18 percentage point lower bounce rate (41% vs 59%), indicating better landing page relevance or more targeted traffic.
- •fda.gov acquires traffic primarily through Search (52%), while nejm.org relies on Direct (40%) — fundamentally different acquisition strategies.
You've seen the gap. Now steal the playbook.
A Growth Teardown reverse-engineers exactly how each product grows — traffic sources, backlink strategy, keyword gaps, and scored action items you can copy this week.
Related Comparisons
Report based on data from July 2026